These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 18990133

  • 1. The safety profile of tadalafil as prescribed in general practice in England: results from a prescription-event monitoring study involving 16 129 patients.
    Hazell L, Cornelius V, Wilton LV, Shakir SA.
    BJU Int; 2009 Feb; 103(4):506-14. PubMed ID: 18990133
    [Abstract] [Full Text] [Related]

  • 2. An observational cohort study investigating the cardiovascular safety of tadalafil when prescribed in primary care in England: mortality due to ischaemic heart disease.
    Hazell L, Boshier A, Harris S, Wilton LV, Shakir SA.
    BJU Int; 2007 Feb; 99(2):387-93. PubMed ID: 17313426
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of the safety of sildenafil for male erectile dysfunction: experience gained in general practice use in England in 1999.
    Boshier A, Wilton LV, Shakir SA.
    BJU Int; 2004 Apr; 93(6):796-801. PubMed ID: 15049992
    [Abstract] [Full Text] [Related]

  • 4. Long-term safety and tolerability of tadalafil in the treatment of erectile dysfunction.
    Montorsi F, Verheyden B, Meuleman E, Jünemann KP, Moncada I, Valiquette L, Casabé A, Pacheco C, Denne J, Knight J, Segal S, Watkins VS.
    Eur Urol; 2004 Mar; 45(3):339-44; discussion 344-5. PubMed ID: 15036680
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Safety profile of orlistat: results of a prescription-event monitoring study.
    Acharya NV, Wilton LV, Shakir SA.
    Int J Obes (Lond); 2006 Nov; 30(11):1645-52. PubMed ID: 16552401
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cardiovascular safety update of Tadalafil: retrospective analysis of data from placebo-controlled and open-label clinical trials of Tadalafil with as needed, three times-per-week or once-a-day dosing.
    Kloner RA, Jackson G, Hutter AM, Mittleman MA, Chan M, Warner MR, Costigan TM, Vail GM.
    Am J Cardiol; 2006 Jun 15; 97(12):1778-84. PubMed ID: 16765134
    [Abstract] [Full Text] [Related]

  • 10. The safety of valsartan: results of a postmarketing surveillance study on 12881 patients in England.
    Biswas PN, Wilton LV, Shakir SW.
    J Hum Hypertens; 2002 Nov 15; 16(11):795-803. PubMed ID: 12444541
    [Abstract] [Full Text] [Related]

  • 11. Likelihood of tadalafil-associated adverse events in integrated multiclinical trial database: classification tree analysis in men with erectile dysfunction.
    Brock G, Glina S, Moncada I, Watts S, Xu L, Wolka A, Kopernicky V.
    Urology; 2009 Apr 15; 73(4):756-61. PubMed ID: 19193420
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of on demand tadalafil in the treatment of East and Southeast Asian men with erectile dysfunction: a randomized double-blind, parallel, placebo-controlled clinical study.
    Yip WC, Chiang HS, Mendoza JB, Tan HM, Li MK, Wang WC, Kopernicky V.
    Asian J Androl; 2006 Nov 15; 8(6):685-92. PubMed ID: 16855765
    [Abstract] [Full Text] [Related]

  • 13. The influence of age on treatment outcomes in men with erectile dysfunction treated with two regimens of tadalafil: results of the SURE study.
    Wespes E, Moncada I, Schmitt H, Jungwirth A, Chan M, Varanese L.
    BJU Int; 2007 Jan 15; 99(1):121-6. PubMed ID: 17227498
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The safety profiles of orlistat and sibutramine: results of prescription-event monitoring studies in England.
    Perrio MJ, Wilton LV, Shakir SA.
    Obesity (Silver Spring); 2007 Nov 15; 15(11):2712-22. PubMed ID: 18070762
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of tadalafil in men with erectile dysfunction following spinal cord injury.
    Giuliano F, Sanchez-Ramos A, Löchner-Ernst D, Del Popolo G, Cruz N, Leriche A, Lombardi G, Reichert S, Dahl P, Elion-Mboussa A, Casariego J.
    Arch Neurol; 2007 Nov 15; 64(11):1584-92. PubMed ID: 17846260
    [Abstract] [Full Text] [Related]

  • 19. Non-arteritic anterior ischemic optic neuropathy (NAION) and phosphodiesterase type-5 inhibitors.
    Bella AJ, Brant WO, Lue TF, Brock GB.
    Can J Urol; 2006 Oct 15; 13(5):3233-8. PubMed ID: 17076943
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.